Fuan Pharmaceutical Group Co (300194) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.023x

Based on the latest financial reports, Fuan Pharmaceutical Group Co (300194) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥100.27 Million ≈ $14.67 Million USD) by net assets (CN¥4.45 Billion ≈ $651.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300194 net asset quality score to measure how much of total assets are equity-financed.

Fuan Pharmaceutical Group Co - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Fuan Pharmaceutical Group Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 300194 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Fuan Pharmaceutical Group Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fuan Pharmaceutical Group Co ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Cars.com Inc NYSE:CARS	0.086x
Talon Metals Corp TO:TLO	-0.005x
Restaurant Brands Asia Limited NSE:RBA	0.232x
Cogent Communications Group Inc NASDAQ:CCOI	-0.079x
Wuhan LinControl Automotive Electronics Co. Ltd. A SHG:688667	0.053x
Keystone Electrical (Zhejiang) Co. Ltd. A SHE:301448	N/A
Southern Cable Group Bhd KLSE:0225	0.036x
Chengdu B-ray Media Co Ltd SHG:600880	-0.001x

Annual Cash Flow Conversion Efficiency for Fuan Pharmaceutical Group Co (2007–2024)

The table below shows the annual cash flow conversion efficiency of Fuan Pharmaceutical Group Co from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Fuan Pharmaceutical Group Co.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.40 Billion ≈ $643.58 Million	CN¥303.59 Million ≈ $44.42 Million	0.069x	-12.95%
2023-12-31	CN¥4.15 Billion ≈ $607.09 Million	CN¥328.98 Million ≈ $48.14 Million	0.079x	-7.82%
2022-12-31	CN¥3.95 Billion ≈ $577.49 Million	CN¥339.50 Million ≈ $49.68 Million	0.086x	+29.34%
2021-12-31	CN¥3.87 Billion ≈ $565.70 Million	CN¥257.13 Million ≈ $37.63 Million	0.067x	+86.38%
2020-12-31	CN¥4.56 Billion ≈ $666.55 Million	CN¥162.55 Million ≈ $23.79 Million	0.036x	-51.84%
2019-12-31	CN¥3.99 Billion ≈ $583.77 Million	CN¥295.63 Million ≈ $43.26 Million	0.074x	+2.27%
2018-12-31	CN¥3.69 Billion ≈ $540.55 Million	CN¥267.68 Million ≈ $39.17 Million	0.072x	-33.34%
2017-12-31	CN¥4.17 Billion ≈ $610.29 Million	CN¥453.37 Million ≈ $66.34 Million	0.109x	+15.16%
2016-12-31	CN¥3.96 Billion ≈ $580.00 Million	CN¥374.16 Million ≈ $54.75 Million	0.094x	+25.23%
2015-12-31	CN¥2.14 Billion ≈ $312.59 Million	CN¥161.03 Million ≈ $23.56 Million	0.075x	+511.64%
2014-12-31	CN¥1.71 Billion ≈ $249.86 Million	CN¥-31.27 Million ≈ $-4.58 Million	-0.018x	-135.25%
2013-12-31	CN¥1.72 Billion ≈ $252.41 Million	CN¥89.61 Million ≈ $13.11 Million	0.052x	+42.41%
2012-12-31	CN¥1.72 Billion ≈ $251.77 Million	CN¥62.77 Million ≈ $9.18 Million	0.036x	-4.80%
2011-12-31	CN¥1.69 Billion ≈ $247.66 Million	CN¥64.85 Million ≈ $9.49 Million	0.038x	-89.82%
2010-12-31	CN¥281.05 Million ≈ $41.13 Million	CN¥105.74 Million ≈ $15.47 Million	0.376x	-2.08%
2009-12-31	CN¥163.31 Million ≈ $23.90 Million	CN¥62.75 Million ≈ $9.18 Million	0.384x	-13.55%
2008-12-31	CN¥110.76 Million ≈ $16.21 Million	CN¥49.23 Million ≈ $7.20 Million	0.444x	-80.47%
2007-12-31	CN¥8.31 Million ≈ $1.22 Million	CN¥18.92 Million ≈ $2.77 Million	2.276x	--

About Fuan Pharmaceutical Group Co

SHE:300194 China Drug Manufacturers - Specialty & Generic

Market Cap

$652.85 Million

CN¥4.46 Billion CNY

Market Cap Rank

#10829 Global

#2928 in China

Share Price

CN¥3.75

Change (1 day)

+0.00%

52-Week Range

CN¥3.34 - CN¥5.02

All Time High

CN¥10.53